Metavention, based in Eden Prairie, MN, is a pioneering company focused on revolutionizing the treatment of high blood pressure and metabolic diseases. Through their innovative iRF Denervation System, they offer a one-time, minimally invasive procedure called renal denervation (RDN) that disrupts overactive sympathetic nerves associated with the kidneys, potentially leading to reduced blood pressure and improved metabolic health.
With a patient-centered approach and a commitment to delivering life-changing therapies, Metavention conducts clinical studies to evaluate the safety and benefits of their iRF Denervation System in patients with high blood pressure. Their team of dedicated scientists and engineers utilize well-established scientific evidence to develop unique treatments that aim to permanently address the underlying causes of hypertension and other metabolic diseases.
Generated from the website
